Clinical Trials Insight: 700045761
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 10 Jun 2009
At a glance
- Drugs Laromustine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Vion Pharmaceuticals
- 10 Jun 2009 New trial record.
- 01 Jun 2009 Data presented at the American Society of Clinical Oncology (ASCO) 2009 annual meeting, according to a Vion media release.